CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 57 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 1,679 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -80.0% | 1,679 | -69.8% | 0.00% | -100.0% |
| Q1 2023 | $5 | -44.4% | 5,552 | -97.6% | 0.00% | – |
| Q4 2022 | $9 | -100.0% | 227,752 | -1.1% | 0.00% | -100.0% |
| Q3 2022 | $34,000 | +100.0% | 230,252 | +2.1% | 0.00% | +100.0% |
| Q2 2022 | $17,000 | -84.8% | 225,500 | -22.7% | 0.00% | -83.3% |
| Q1 2022 | $112,000 | +86.7% | 291,700 | +130.7% | 0.01% | +100.0% |
| Q4 2021 | $60,000 | -28.6% | 126,416 | -35.5% | 0.00% | -25.0% |
| Q3 2021 | $84,000 | +171.0% | 196,100 | +410.7% | 0.00% | +100.0% |
| Q2 2021 | $31,000 | – | 38,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 188,796 | $291,000 | 0.08% |
| Horst & Graben Wealth Management LLC | 75,722 | $117,000 | 0.03% |
| Alpine Global Management, LLC | 83,475 | $129,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $77,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,863 | $48,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 49,075 | $76,000 | 0.00% |
| Alberta Investment Management Corp | 172,185 | $265,000 | 0.00% |
| Syverson Strege & Co | 2,145 | $3,000 | 0.00% |
| HighTower Advisors, LLC | 170,623 | $263,000 | 0.00% |
| HRT FINANCIAL LP | 90,871 | $139,000 | 0.00% |